SCHEMBL6062287

SCHEMBL6062287

NCC1CNC(=O)C1.[NaH]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24718815 0.98
SCHEMBL523027 0.98
SCHEMBL523028 0.98
Hydrochloric Acid SCHEMBL30111345 0.95
Hydrochloric Acid SCHEMBL1700412 0.95
Cadaverine Tartrate SCHEMBL9456630 0.82 GBA1 (0.34)
SCHEMBL22574702 0.80
Hydrochloric Acid SCHEMBL16992674 0.78 SYK (0.31)
SCHEMBL30497308 0.77
SCHEMBL2032083 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1732561-A1 COMBINATION OF CB2 MODULATORS AND PDE4 INHIBITORS FOR USE IN MEDICINE GLAXO GROUP LIMITED (GB) 2006-12-20 EP disclosed
WO-2005074939-A1 COMBINATION OF CB2 MODULATORS AND PDE4 INHIBITORS FOR USE IN MEDICINE GLAXO GROUP LIMITED (GB) 2005-08-18 WO disclosed